Showing 161 - 180 results of 11,661 for search '(( 50 ms decrease ) OR ((( 50 ((nn decrease) OR (we decrease)) ) OR ( e non decrease ))))', query time: 0.48s Refine Results
  1. 161
  2. 162
  3. 163

    Distribution Coefficients of the REEs, Sr, Y, Ba, Th, and U between α‑HIBA and AG50W-X8 Resin by Haoyu Li (1672648)

    Published 2020
    “…However, only limited REE partition data between α-HIBA and cation resins exist, which makes it challenging to develop and optimize purification techniques using this platform. Here, we report distribution coefficients (<i>K</i><sub>d</sub>) of REEs, as well as Sr, Y, Ba, Th, and U, between α-HIBA at pH = 4.50 and AG50W-X8 cation-exchange resin, obtained by batch equilibration experiments. …”
  4. 164
  5. 165
  6. 166

    Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…No recurrence of RVO-ME was observed during follow-ups at 6 months <b>(E)</b>, 1 year <b>(G)</b>, and 3 years (I) postoperatively. …”
  7. 167
  8. 168
  9. 169
  10. 170
  11. 171

    Downregulation of TRIM37 expression exacerbates pathological damage in the MS model. by Lai Jiang (2401513)

    Published 2025
    “…<b>(f, g)</b> TUNEL staining (n = 3) demonstrated a significant increase in the apoptosis rate in the model group compared to the control group. Scale bar = 50 μm. (h) qRT-PCR (n = 6) and <b>(i, j)</b> Western blot (n = 3) both showed a significant decrease in the <i>TRIM37</i> mRNA and protein levels in the LPC-induced MS model compared to the control group. * <i><i>P</i></i> < 0.05, ** <i><i>P</i></i> < 0.01, *** <i><i>P</i></i> < 0.001, **** <i><i>P</i></i> < 0.0001, ns = not significant.…”
  12. 172
  13. 173
  14. 174
  15. 175
  16. 176

    Subgroup analysis of eGFR based on pump type. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    “…However, there was no difference between the two methods on BUN, ALT, AST, eGFR, ARF, and death. Most of the outcomes showed significant heterogeneity, which requires more robust RCTs to be conducted to increase the quality and the certainty of evidence.…”
  17. 177
  18. 178
  19. 179
  20. 180